Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts

Ryvu Therapeutics

Market Cap: zł510.3m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

Captor Therapeutics Spolka Akcyjna

Market Cap: zł223.4m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

Molecure

Market Cap: zł148.9m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.

Poltreg

Market Cap: zł121.2m

A biotechnology company, researches and develops therapies for autoimmune diseases.